Cyana Therapeutics, LLC, 2025-12-22
An SEC Form D private-offering notice from Miami Beach, FL, an undisclosed offering target in Biotech. Filed 2025-12-22. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Cyana Therapeutics is a precision immuno-oncology biotech developing an ENPP1 inhibitor drug intended to restore immune recognition of solid tumors.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Cadrenal Therapeutics, Inc., 2025-12-31, $4.4M, Ponte Vedra, FL
- Enveric Biosciences, Inc., 2025-12-23, $107K, Cambridge, MA
- Governly, Inc., 2025-12-29, $200K, Fort Lauderdale, FL
- AETHLON MEDICAL INC, 2025-12-23, $2.2M, San Diego, CA
- Odyssey Wellness LLC, 2025-12-29, $20M, Fort Lauderdale, FL
- Addition Therapeutics, Inc., 2025-12-22, $28M, South San Francisco, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.